PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer Huan-** ZhangRui-yuan Jiang**ao-jia Wang Review Article Open access 17 April 2024 Pages: 539 - 551
Association between quality of life and mortality risk in patients with breast cancer: a systematic review and meta-analysis Katsuyoshi SuzukiShinichiro MorishitaTakuya Fukushima Review Article 09 April 2024 Pages: 552 - 561
The usefulness of artificial intelligence in breast reconstruction: a systematic review Karla C. MaitaFrancisco R. AvilaAntonio Jorge Forte Review Article 15 April 2024 Pages: 562 - 571
Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases Alexandre De MouraDelphine LoiratAlexandre Acramel Original Article Open access 10 April 2024 Pages: 572 - 580
Real-world data of HER2-negative early breast cancer patients treated with anthracycline and/or taxane regimens in Japan Akihiko ShimomuraYasuaki SagaraShigehira Saji Original Article Open access 29 April 2024 Pages: 581 - 592
Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from microarray data from fresh-frozen to FFPE tissues Akira WatanabeRyo TsunashimaYasuto Naoi Original Article 08 April 2024 Pages: 593 - 606
Exosomal lncRNA SNHG12 promotes angiogenesis and breast cancer progression Yan ChenYuxin ZhouWeizhu Wu Original Article Open access 04 June 2024 Pages: 607 - 620
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study Tetsuhiro YoshinamiShigenori E. NagaiNorikazu Masuda Original Article Open access 20 April 2024 Pages: 621 - 632
French national survey on breast cancer care: caregiver and patient views Christine Rousset-JablonskiBarbara LortalAlain Toledano Original Article Open access 18 April 2024 Pages: 633 - 642
Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study Peter J. K. TokudaTakamasa Mitsuyoshithe Kyoto Radiation Oncology Study Group Original Article Open access 12 April 2024 Pages: 643 - 648
Nipple–areolar complex malposition in breast reconstruction after nipple-sparing mastectomy: a multi-institutional retrospective observational study in Japan Sayuri KatoHiroki Morithe Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society Original Article 08 April 2024 Pages: 649 - 658
Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors Pei-**g YangEing-Mei TsaiTsu-Nai Wang Original Article 23 April 2024 Pages: 659 - 670
Inter- and intra-observer variability of qualitative visual breast-composition assessment in mammography among Japanese physicians: a first multi-institutional observer performance study in Japan Yoichi KoyamaKazuaki NakashimaTakayoshi Uematsu Original Article 15 April 2024 Pages: 671 - 683
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database Yuhang ShangXuelian WangBaoliang Guo Original Article Open access 21 April 2024 Pages: 684 - 694
Percutaneous ultrasound-guided cryoablation for early-stage primary breast cancer: a follow-up study in Japan Hisanori KawamotoKoichiro TsugawaMamoru Fukuda Original Article Open access 27 April 2024 Pages: 695 - 704
Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status Sei NaMilim KimSo Yeon Park Original Article Open access 21 April 2024 Pages: 705 - 716
Adverse effects of tamoxifen treatment on bone mineral density in premenopausal patients with breast cancer: a systematic review and meta-analysis Soo ** LeeChihwan David ChaMin Sung Chung Original Article 27 April 2024 Pages: 717 - 725
Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients Yong-qiang BaoTeng-hua YuChun-ling Jiang Original Article Open access 05 May 2024 Pages: 726 - 734
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients Kadri Altundag Letter to the Editor 22 April 2024 Pages: 735 - 735
Correction: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment Yutaka YamamotoChikako YamauchiShigehira Saji Correction Open access 12 May 2024 Pages: 736 - 737
